{"pressReleaseArticle":{"contentWrapper":{"title":"FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States","intro":"

First combination of ibuprofen and acetaminophen for pain relief to be available OTC in 2020

","publishDateTime":"02/03/2020 00:00:00","publishDate":"March 02 2020","forInvestorsAndMediaOnlyText":"","shortDescription":"GSK announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief.","image":null,"downloadLink":null,"tags":[]},"components":[{"type":"rich-text","text":"

Issued: Warren, US

\n

GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. The exclusive formula is now the first FDA-approved OTC combination of ibuprofen and acetaminophen in the United States and will be available over-the-counter nationwide in 2020.

\n

Franck Riot, Head of R&D, GSK Consumer Healthcare said: “For decades, many consumers have been using ibuprofen and acetaminophen to get the benefits of both active ingredients when safely treating their headaches, muscle aches, backaches, arthritis and other joint pain. Now Advil, the No. 1 selling OTC pain reliever, will offer US consumers the first-ever alternative option -- a single, fixed-dose combination pain reliever. As the world-leader in pain relief, Advil Dual Action and our recently FDA-approved Voltaren Arthritis Pain gel, demonstrates GSK’s commitment to providing new safe, effective and convenient pain relief options for consumers.”

\n

Advil Dual Action provides relief for multiple symptoms and is the first formulation that combines ibuprofen and acetaminophen, two powerful ingredients indicated for OTC pain relief that work in different ways.

\n

The submission in support of today’s approval of Advil Dual Action was based on data from seven clinical studies, three of which were pivotal efficacy and safety studies in pain relief. The data supports a pain relief indication and demonstrates that the fixed-dose combination achieves superior efficacy compared to the individual monocomponents of ibuprofen (250mg) and acetaminophen (500mg) alone (as evidenced by appreciable improvements in acute pain symptoms across multiple pre-specified endpoints). 

\n

About Advil Dual Action

\n

Advil Dual Action is an exclusive pain-fighting formula, combining ibuprofen and acetaminophen to fight pain in two ways. Ibuprofen is a nonsteroidal anti-inflammatory (NSAID) that targets pain at the source, temporarily reducing the production of prostaglandins, which cause swelling and pain signals. Acetaminophen is a pain reliever that blocks the transmission of pain signals to the brain. Advil Dual Action will be available over-the-counter nationwide in 2020.

\n

GSK’s commitment to pain relief

\n

We are the world leader in pain relief. With a portfolio of (systemic and topical) products to relieve pain, our range brings comfort and ease to millions. World-leading brands including Advil, Panadol and Voltaren; and beloved local brands like Excedrin in the US and Fenbid in China help people manage their symptoms so they can enjoy life to the fullest.

\n

Important safety information about Advil Dual Action

\n

Before using the product, consumers should read the Advil Dual Action drug facts label. 

\n

About GSK

\n

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com. 

\n

About GSK Consumer Healthcare

\n

We are the world’s largest Consumer Healthcare company following our new joint venture with Pfizer Consumer Healthcare. The new drug application for Advil Dual Action was approved under the Pfizer name. We develop and market a portfolio of consumer-preferred and expert-recommended brands including Sensodyne, parodontax, Poligrip, Advil, Centrum and Theraflu.

\n

Cautionary statement regarding forward-looking statements

\n

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Principal risks and uncertainties' in the company's Annual Report on Form 20-F for 2018.

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

GSK enquiries:

\n		\n

 

\n		\n

 

\n		\n

 

\n
\n

UK Media enquiries:

\n		\n

Simon Steel

\n		\n

+44 (0) 20 8047 5502

\n		\n

(London)

\n
\n

 

\n		\n

Eleanor Bunch

\n		\n

+44 (0) 20 8047 5502

\n		\n

(London)

\n
\n

 

\n		\n

 

\n		\n

 

\n		\n

 

\n
\n

US Media enquiries:

\n		\n

Caitlin Kormann

\n		\n

+1 617 448 0557

\n		\n

(Warren)

\n
\n

 

\n		\n

 

\n		\n

 

\n		\n

 

\n
\n

Analyst/Investor enquiries:

\n		\n

Sarah Elton-Farr

\n		\n

+44 (0) 208 047 5194

\n		\n

(London)

\n
\n

 

\n		\n

Danielle Smith

\n		\n

+44 (0) 20 8047 7562

\n		\n

(London)

\n
\n

 

\n		\n

James Dodwell

\n		\n

+44 (0) 20 8047 2406

\n		\n

(London)

\n
\n

 

\n		\n

Jeff McLaughlin

\n		\n

+1 215 751 7002

\n		\n

(Philadelphia)

\n
\n

 

","useGreyBackground":false,"fullWidth":false},{"type":"varied-signpost-grid","title":"","layoutPattern":4,"pages":[{"title":"Media","content":"US resources, press releases, information on our social media channels, and our photo and video library","image":{"src":"/media/qnlgziui/two-people-about-to-go-on-air-1.jpg?width=427&height=533&format=webp&quality=100&v=1dc83ee6344a350","alt":"Two people on set.","darkModeSrc":"/media/qnlgziui/two-people-about-to-go-on-air-1.jpg?width=427&height=533&format=webp&quality=90&v=1dc83ee6344a350"},"link":{"text":"Media","href":"/en-us/media/","openInNewWindowText":null}},{"title":"Company","content":"We unite science, technology and talent to get ahead of disease together","image":{"src":"/media/suilv4ve/dna-and-tech-science-image-rgb.jpg?width=427&height=533&format=webp&quality=100&v=1dcd7c357a61910","alt":"DNA And Tech Science Image","darkModeSrc":"/media/suilv4ve/dna-and-tech-science-image-rgb.jpg?width=427&height=533&format=webp&quality=90&v=1dcd7c357a61910"},"link":{"text":"Company","href":"/en-us/company/","openInNewWindowText":null}}],"hidePageDescription":false,"useGreyBackground":false}]},"id":5520,"docCheckLogout":null,"pageType":"pressReleasePage","languageCode":"en-US","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-us/","openInNewWindowText":null},{"text":"Media","href":"/en-us/media/","openInNewWindowText":null},{"text":"Press releases","href":"/en-us/media/press-releases/","openInNewWindowText":null},{"text":"FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States","href":"/en-us/media/press-releases/fda-approves-gsk-s-advil-dual-action-with-acetaminophen-for-over-the-counter-use-in-the-united-states/","openInNewWindowText":null}]},"pageName":"FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-us/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":false,"text":"United States (EN)"},"languageSelector":{"currentLanguage":null,"currentLanguageMobile":null,"selectableLanguages":[]},"darkModeSwitch":{"text":"Dark Mode","tooltipText":"

Switch to dark mode to head towards a more sustainable world together. More info

"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"locationSelector":{"text":"Change location","href":"/en-us/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-us/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":true,"title":"Behind the Science US edition","url":"/en-us/behind-the-science-us-edition/","nodes":[],"isActive":false,"promos":[]},{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-us/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-us/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"Respiratory, immunology and inflammation","url":"/en-us/company/respiratory-immunology-and-inflammation/","nodes":[],"isActive":false},{"title":"Oncology","url":"/en-us/company/oncology/","nodes":[{"title":"Myelofibrosis","url":"/en-us/company/oncology/myelofibrosis/","nodes":[],"isActive":false},{"title":"Ovarian cancer","url":"/en-us/company/oncology/ovarian-cancer/","nodes":[],"isActive":false},{"title":"Endometrial cancer","url":"/en-us/company/oncology/endometrial-cancer/","nodes":[],"isActive":false},{"title":"Multiple myeloma","url":"/en-us/company/oncology/multiple-myeloma/","nodes":[],"isActive":false},{"title":"Rectal cancer","url":"/en-us/company/oncology/rectal-cancer/","nodes":[],"isActive":false}],"isActive":false},{"title":"HIV","url":"/en-us/company/hiv/","nodes":[],"isActive":false},{"title":"Infectious diseases","url":"/en-us/company/infectious-diseases/","nodes":[{"title":"Vaccines","url":"/en-us/company/infectious-diseases/vaccines/","nodes":[],"isActive":false},{"title":"Flu","url":"/en-us/company/infectious-diseases/flu/","nodes":[],"isActive":false},{"title":"Shingles (Herpes Zoster)","url":"/en-us/company/infectious-diseases/shingles-herpes-zoster/","nodes":[],"isActive":false},{"title":"RSV (Respiratory Syncytial Virus)","url":"/en-us/company/infectious-diseases/rsv-respiratory-syncytial-virus/","nodes":[],"isActive":false},{"title":"Meningitis","url":"/en-us/company/infectious-diseases/meningitis/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Global Outstanding people","image":{"src":"/media/kjtduuwb/20250115-extra-6-phl-small.jpg?width=329&height=185&format=webp&quality=100&v=1dbe12238ee2370","alt":"Two people walking in an office","darkModeSrc":"/media/kjtduuwb/20250115-extra-6-phl-small.jpg?width=329&height=185&format=webp&quality=90&v=1dbe12238ee2370"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/outstanding-people/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global policy positions","image":{"src":"/media/diaofnw2/20250115-extra-14-phl.jpg?width=329&height=185&format=webp&quality=100&v=1dbe122233e8880","alt":"An employee attending an online meeting","darkModeSrc":"/media/diaofnw2/20250115-extra-14-phl.jpg?width=329&height=185&format=webp&quality=90&v=1dbe122233e8880"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/policy-positions","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-us/innovation/","nodes":[{"title":"Therapeutic areas","url":"/en-us/innovation/therapeutic-areas/","nodes":[],"isActive":false},{"title":"Technologies","url":"/en-us/innovation/technologies/","nodes":[],"isActive":false},{"title":"Clinical studies","url":"/en-us/innovation/clinical-studies/","nodes":[{"title":"Representative clinical trials","url":"/en-us/innovation/clinical-studies/representative-clinical-trials/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Global pipeline","image":{"src":"/media/zr0acsx2/20281231-c1-innovation-um.jpg?width=329&height=185&format=webp&quality=100&v=1dc8fa7a9f728d0","alt":"A close-up shot of scientist's hands handling a vial","darkModeSrc":"/media/zr0acsx2/20281231-c1-innovation-um.jpg?width=329&height=185&format=webp&quality=90&v=1dc8fa7a9f728d0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/innovation/pipeline/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global Behind the science magazine","image":{"src":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?width=329&height=185&format=webp&quality=100&v=1dcc04016a69c90","alt":"GSK Tech Human Image","darkModeSrc":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?width=329&height=185&format=webp&quality=90&v=1dcc04016a69c90"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/behind-the-science-magazine/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-us/products/","nodes":[],"isActive":false,"promos":[]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-us/responsibility/","nodes":[{"title":"Inclusion","url":"/en-us/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"US charitable investments","url":"/en-us/responsibility/us-charitable-investments/","nodes":[{"title":"Charitable grants","url":"/en-us/responsibility/us-charitable-investments/charitable-grants/","nodes":[],"isActive":false}],"isActive":false},{"title":"Ethical standards","url":"/en-us/responsibility/ethical-standards/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Access to medicines","image":{"src":"/media/q2cllvad/20271231-a1-careers-up.jpg?width=329&height=185&format=webp&quality=100&v=1dbe1221dd270f0","alt":"A scientist checking experiment results in the lab","darkModeSrc":"/media/q2cllvad/20271231-a1-careers-up.jpg?width=329&height=185&format=webp&quality=90&v=1dbe1221dd270f0"},"link":{"text":"FEATURED WEBSITE","href":"https://www.gskforyou.com/","openInNewWindowText":null}},{"text":"Global Responsibility ","image":{"src":"/media/e5nbvffs/20250115-f4-ethical-standards-um.jpg?width=329&height=185&format=webp&quality=100&v=1dbe1221ed9f5e0","alt":"A smiling scientist posing in the lab","darkModeSrc":"/media/e5nbvffs/20250115-f4-ethical-standards-um.jpg?width=329&height=185&format=webp&quality=90&v=1dbe1221ed9f5e0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/responsibility/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-us/media/","nodes":[{"title":"Press releases","url":"/en-us/media/press-releases/","nodes":[],"isActive":true},{"title":"Media contacts","url":"/en-us/media/media-contacts/","nodes":[],"isActive":false},{"title":"In Focus","url":"/en-us/media/in-focus/","nodes":[{"title":"Flu is a Family Affair","url":"/en-us/media/in-focus/flu-is-a-family-affair/","nodes":[],"isActive":false}],"isActive":false}],"isActive":true,"promos":[{"text":"Global press releases","image":{"src":"/media/svplhxgn/20271231-h2-visit-our-global-careers-site-link-um.jpg?width=329&height=185&format=webp&quality=100&v=1dbe12238bed610","alt":"Two employees discussing work in the office","darkModeSrc":"/media/svplhxgn/20271231-h2-visit-our-global-careers-site-link-um.jpg?width=329&height=185&format=webp&quality=90&v=1dbe12238bed610"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/media/press-releases/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-us/careers/","nodes":[{"title":"Search jobs","url":"/en-us/careers/search-jobs/","nodes":[],"isActive":false},{"title":"Life at GSK","url":"/en-us/careers/life-at-gsk/","nodes":[{"title":"Employment rights under federal law","url":"/en-us/careers/life-at-gsk/employment-rights-under-federal-law/","nodes":[],"isActive":false}],"isActive":false},{"title":"Experienced professionals","url":"/en-us/careers/experienced-professionals/","nodes":[{"title":"A career in oncology","url":"/en-us/careers/experienced-professionals/a-career-in-oncology/","nodes":[],"isActive":false},{"title":"A career in Boston","url":"/en-us/careers/experienced-professionals/a-career-in-boston/","nodes":[],"isActive":false}],"isActive":false},{"title":"Early careers","url":"/en-us/careers/early-careers/","nodes":[{"title":"Apprentices","url":"/en-us/careers/early-careers/apprentices/","nodes":[],"isActive":false},{"title":"Internships and co-ops","url":"/en-us/careers/early-careers/internships-and-co-ops/","nodes":[],"isActive":false},{"title":"Scientific leadership program","url":"/en-us/careers/early-careers/scientific-leadership-program/","nodes":[],"isActive":false},{"title":"Commercial development program","url":"/en-us/careers/early-careers/commercial-development-program/","nodes":[],"isActive":false}],"isActive":false},{"title":"Veterans at GSK","url":"/en-us/careers/veterans-at-gsk/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global how we hire","image":{"src":"/media/3u2dneiw/20271231-a3-contact-us-phl.jpg?width=329&height=185&format=webp&quality=100&v=1dbe12236d41d10","alt":"Three employees meeting in the office","darkModeSrc":"/media/3u2dneiw/20271231-a3-contact-us-phl.jpg?width=329&height=185&format=webp&quality=90&v=1dbe12236d41d10"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/how-we-hire/","openInNewWindowText":null}},{"text":"Global graduate program","image":{"src":"/media/xrsfni0a/20281231-h4a-achieve-your-career-goals-up.jpg?width=329&height=185&format=webp&quality=100&v=1dbe1221e21c970","alt":"A smiling scientist posing in the lab","darkModeSrc":"/media/xrsfni0a/20281231-h4a-achieve-your-career-goals-up.jpg?width=329&height=185&format=webp&quality=90&v=1dbe1221e21c970"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme","openInNewWindowText":null}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1702","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-us/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"

This is our US website, intended for US audiences only. Other market sites can be reached by visiting our location selector.

\n

© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

\n

GSK plc. Registered in England and Wales No. 3888792.

\n

Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG

","modernSlaveryStatement":null,"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on LinkedIn","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gskus?igsh=dDl0NjZmbmlia3F1","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"},{"globalLink":{"text":null,"href":"https://www.threads.com/@gskus","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Threads","customIcon":null,"showPopupMenu":false,"type":"Threads"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Facebook","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Youtube","customIcon":null,"showPopupMenu":false,"type":"Youtube"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"GSK Global website","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Locations selector","href":"/en-us/locations/","openInNewWindowText":null},{"text":"Global Behind the science","href":"https://www.gsk.com/en-gb/behind-the-science/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSKPro for HCPs","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK study register","href":"https://www.gsk-studyregister.com/en/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Business to Business","href":"/en-us/business-to-business-in-the-us/","openInNewWindowText":null},{"text":"Supplier website","href":"https://supplier.gsk.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Behind the science US edition","href":"/en-us/behind-the-science-us-edition/","openInNewWindowText":null},{"text":"Company","href":"/en-us/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-us/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-us/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-us/responsibility/","openInNewWindowText":null},{"text":"Media","href":"/en-us/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-us/careers/","openInNewWindowText":null}]},{"columnTitle":"Global investors","links":[{"text":"Shareholders","href":"https://www.gsk.com/en-gb/investors/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Quarterly results","href":"https://www.gsk.com/en-gb/investors/quarterly-results/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Financial reports","href":"https://www.gsk.com/en-gb/investors/financial-reports/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Share price analysis","href":"https://www.gsk.com/en-gb/investors/dividend-and-share-price/","openInNewWindowText":null},{"text":"Product pipeline","href":"https://www.gsk.com/en-gb/innovation/pipeline/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-us/contact-us/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-us/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-us/accessibility/","openInNewWindowText":null},{"text":"Digital sustainability","href":"/en-us/digital-sustainability/","openInNewWindowText":null},{"text":"Terms of use","href":"/en-us/terms-of-use/","openInNewWindowText":null},{"text":"Cookie policy","href":"/en-us/cookie-policy/","openInNewWindowText":null},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-us/privacy-notice/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-us/sitemap/","openInNewWindowText":null}],"continueToLink":null,"legalApprovalText":""},"sharing":{"description":"GSK announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief.","og":[{"property":"og:title","content":"FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States"},{"property":"og:description","content":"GSK announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief."},{"property":"og:image","content":"https://us.gsk.com/media/gdvhctix/scientist-testing-biological-samples.jpg?width=600&format=webp&quality=100&v=1dcc1f03f5ccb30"},{"property":"og:url","content":"https://us.gsk.com/en-us/media/press-releases/fda-approves-gsk-s-advil-dual-action-with-acetaminophen-for-over-the-counter-use-in-the-united-states/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"FDA approves GSK’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States"},{"name":"twitter:description","content":"GSK announced that the U.S. FDA has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief."},{"name":"twitter:image","content":"https://us.gsk.com/media/gdvhctix/scientist-testing-biological-samples.jpg?width=600&format=webp&quality=100&v=1dcc1f03f5ccb30"},{"name":"twitter:url","content":"https://us.gsk.com/en-us/media/press-releases/fda-approves-gsk-s-advil-dual-action-with-acetaminophen-for-over-the-counter-use-in-the-united-states"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":true,"title":"You are leaving our website","texts":"

The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.

","continueText":"Continue","cancelText":"Cancel","exclusionUrls":["https://www.gsk.com","https://www.facebook.com/GSK","http://doingmoreintheus.gsk.com/en-us/map-regions/","https://www.gsk.com/en-gb","https://www.gsk.com/en-gb/investors/quarterly-results/","https://www.gsk.com/en-gb/about-us/vaccines/why-you-don-t-outgrow-vaccination/","https://www.gsk.com/en-gb/behind-the-science/patients-consumers/eggs-in-manufacturing/","https://innovation.gsk.com/","http://doingmoreintheus.gsk.com/en-us/map-regions/north-carolina/doing-more-on-moore-drive-in-the-research-triangle-park/","http://doingmoreintheus.gsk.com/en-us/map-regions/pennsylvania/gsk-navy-yard-where-we-do-more-with-less/","https://www.gsk.com/en-gb/about-us/save-the-children-partnership","https://www.gskgrants.com","https://www.gskforyou.com/","http://fortherecord.payments.us.gsk.com","https://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","http://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","https://www.gsk.com/en-gb/products/stiefel-dermatology/","https://www.gsk.com/en-gb/products/viiv-healthcare/","https://www.contactus.gsk.com/callback/index.html","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsksource.com/pharma/content/gsk/source/us/en.html","http://www.msds-gsk.com/","https://www.gsk.com/en-gb/investors/shareholder-information/","http://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/investors/corporate-reporting/","https://www.gsk.com/en-gb/investors/product-pipeline/","http://www.gskgrants.com/","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsk.com/media/2941/human-rights-statement-policy.pdf","http://www.gsk.com/media/280848/human-rights-statement-policy.pdf","http://www.gsk.com/en-gb/research/rd-locations/pharmaceuticals/","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","http://twitter.com/GSK","http://www.youtube.com/GSK","http://www.flickr.com/photos/glaxosmithkline","http://www.linkedin.com/company/glaxosmithkline","https://www.instagram.com/gsk/ ","http://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/media/press-releases/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-impact-and-appropriate-use-of-corticosteroids-in-sle-management/","https://www.gsk.com/en-gb/behind-the-science/our-people/from-tv-to-tackling-lupus-why-alex-moved-from-media-to-medicine/","http://www.gskforyou.com/","http://us.gsk.com/en-us/behind-the-science/?tag=Corporate+responsibility","https://www.gskforyou.com/prescription-resource-assistance/immunology-respiratory/","https://www.contactus.gsk.com/callback.html","https://www.gsk.com/en-gb/about-us/governance/global-compliance/","https://www.gsk.com/en-gb/careers/physicians/","https://www.gsk.com/en-gb/careers/job-finder/","https://www.gsk.com/en-gb/contact-us/worldwide/","https://access.gsk.com/password/","https://access.gsk.com/selfservice/static/login.jsp?TYPE=33554433&REALMOID=06-c7edf5ec-5585-100d-83b1-84797f88fc89&GUID=&SMAUTHREASON=0&METHOD=GET&SMAGENTNAME=-SM-90R5K5a0NsTyKRhPyTIn3A3B5ovKkqcehflGRUrUNusjZdRaPY%2bWUozEFizs1bMg&TARGET=-SM-https%3a%2f%2fuksah%2egsk%2ecom%2fswh_uk_win_ns%2fcommunications%2femployee%2femployees%2ehtm","https://www.gsk.com/en-gb/responsibility/operating-responsibly/working-with-third-parties/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://ascend.cvmsolutions.com/Account/Login?client=gsk","https://twitter.com/GSKUS","https://twitter.com/GSK","https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf","https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/","https://www.gsk.com/media/2538/gsk-materiality-process.pdf","https://www.gsk.com/en-gb/responsibility/access-to-healthcare/","https://www.gsk.com/en-gb/responsibility/our-people/","https://www.gsk.com/en-gb/responsibility/environment/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/","https://www.gsk.com/media/4552/our-code-of-practice.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=10","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.instagram.com/gsk/","https://twitter.com/gsk","https://twitter.com/gskus","https://www.youtube.com/GSK","https://www.gsk.com/en-gb/media/resource-centre/","https://www.gsk.com/en-gb/media/image-and-video-library/","https://www.gsk.com/en-gb/media/rss-feeds/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf","https://www.gsk.com/en-gb/careers/meet-our-people/","https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/","https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","https://gskearlytalent.avature.net/landingpage","https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","https://www.gsk.com/en-gb/research/our-approach/open-innovation/","https://www.gsk.com/en-gb/careers/careers-search/?r=USA","https://www.linkedin.com/company/gsk-canada/","https://www.linkedin.com/company/gsk_consumer_healthcare_india/","https://www.linkedin.com/company/gsk-pharmaceuticals-india/","https://www.linkedin.com/company/glaxosmithkline-poland/","https://www.youtube.com/user/gskasiachannel/","https://www.youtube.com/channel/UChWuz9ZDceHYHXmJVJ4hF8Q","https://www.youtube.com/channel/UCN1XeWQWLVhFLHQwZl93jFQ","https://www.youtube.com/channel/UCwQyIfV4pLlsZGuN7fiZm2w","https://twitter.com/gsk_ar","https://twitter.com/GSK_Asia","https://twitter.com/gsk_conferences","https://twitter.com/gsk_au","https://twitter.com/GSK_DE","https://twitter.com/GSKCH_INDIA","https://twitter.com/GSK_IE","https://twitter.com/gsk_it","https://twitter.com/GSKScience","https://twitter.com/stiefel","https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/","https://www.gsk.com/en-gb/behind-the-science/innovation/the-digitalisation-lab-bringing-the-digital-age-to-manufacturing/","https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","http://uk.gsk.com/en-gb/careers/apprenticeships/","https://www.gsk.com/media/4931/gsk-quick-facts.pdf","https://ie.gsk.com/ie/careers/apprenticeships/","http://au.gsk.com/en-au/careers/apprenticeships/","http://sg.gsk.com/en-sg/careers/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/","https://gsk.i-sight.com/landing-page/","https://www.gskforyou.com/","https://jobs.gsk.com/en-us/jobs?keywords=RichmondConsumerHealthcareR%26D&page=1","https://jobs.gsk.com/en-us/jobs?page=1&location=Lincoln,%20NE,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=Carlisle,%20PA,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=East%20Durham,%20NY,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://us.gsk.com/en-us/media/press-releases/fda-approves-parp-inhibitor-in-first-line-monotherapy-maintenance-treatment-for-women-with-platinum-responsive-advanced-ovarian-cancer-regardless-of-biomarker-status/","https://privacy.gsk.com/en-us/privacy-notice/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2020/","https://www.gsk.com/en-gb/careers/","https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-fy-2021-reported-sales-of-34-billion-stable-at-aer-plus5-cer/","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2021/","https://www.gsk.com/media/7473/esg-performance-report-2021.pdf","https://www.gsk.com/en-gb/company/codes-standards-and-reports/","https://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/media/our-response-to-covid-19/","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://www.gsk.com/en-gb/media/","https://www.gsk.com/en-gb/behind-the-science/","https://gskpro.com/","https://viivhealthcare.com/","https://www.gsk-studyregister.com/en/","https://gsk.supplierone.co/","https://www.gsk.com/en-gb/investors/financial-reports/","https://www.gsk.com/en-gb/investors/dividend-and-share-price/","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/speakup","https://www.gsk.com/en-gb/company/outstanding-people/","https://www.gsk.com/en-gb/company/policy-positions","https://www.gsk.com/en-gb/research-and-development/our-approach-to-rd/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/en-gb/company/policy-positions/#","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://www.togetherwithgskoncology.com/","https://www.gsk.com/en-gb/behind-the-science/looking-deeper-into-lupus/","https://gateway.on24.com/wcc/eh/3471076/Patient+Engagement+Hub","https://www.gsk.com/en-gb/behind-the-science/following-the-science-of-oxygen-to-discover-solutions-for-anaemia/","https://www.multivu.com/players/English/8857131-gsk-ask2bsure-meningitis-b-vaccination/","https://www.gsk.com/en-gb/innovation/rd-locations/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/","https://www.gsk.com/en-gb/behind-the-science/mrna-messenger-ribonucleic-acid-disrupting-the-field-of-vaccinology/","https://www.gsk.com/en-gb/behind-the-science/inside-the-vaccine-factory-of-the-future/","https://www.gsk-studyregister.com/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/diversity-equity-and-inclusion/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://www.gsk.com/media/8518/policies-and-standards.pdf","https://www.gsk.com/en-gb/company/governance/compliance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/working-with-third-parties/","https://www.gsk.com/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","https://www.gsk.com/en-gb/responsibility/ethical-standards/human-rights/","https://www.gsk.com/en-gb/responsibility/ethical-standards/use-of-animals/","https://www.gsk.com/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","https://www.gsk.com/en-gb/media/press-releases/","https://annualreport.gsk.com/","https://www.gsk.com/en-gb/media/media-contacts/","https://www.gsk.com/en-gb/media/media-library/","https://www.gsk.com/en-gb/media/social-media/","https://www.gsk.com/en-gb/media/our-response-to-the-situation-in-ukraine/","https://jobs.gsk.com/en-us/jobs?keywords=%23ApprenticeUS&location=&lang=en-us","https://www.gsk.com/en-gb/behind-the-science/advancing-the-next-generation-of-immuno-oncology/","https://www.gsk.com/en-gb/behind-the-science/synthetic-lethality-outmanoeuvring-the-cancer-genome/","https://www.gsk.com/en-gb/media/press-releases/gsk-and-lyell-immunopharma-join-forces-to-develop-the-next-generation-of-cancer-cell-therapies/","https://jobs.gsk.com/en-us/jobs?keywords=oncology&page=1","https://jobs.gsk.com/en-us/jobs?keywords=oncology&page=1","https://www.gsk.com/en-gb/research-and-development/our-pipeline/","https://jobs.gsk.com/en-us/jobs?keywords=%23WYARD2022&location=&lang=en-us","https://jobs.gsk.com/en-us/jobs?keywords=%23WYAcommerical2022&lang=en-us&sortBy=relevance&page=1","https://jobs.gsk.com/en-us/jobs?keywords=%23WYAGSC2022&lang=en-us&sortBy=relevance&page=1","https://jobs.gsk.com/en-us/jobs?lang=en-us&sortBy=relevance&page=1&location=United%20States&woe=12&stretchUnit=MILES&stretch=10","https://www.gsk.com/media/8520/the-code-presentation-version.pdf","https://www.gsk.com/en-gb/careers/featured-careers/","https://www.gsk.com/en-gb/careers/how-we-hire/","https://www.gsk.com/en-gb/careers/our-global-and-regional-hubs/","https://www.gsk.com/en-gb/careers/how-we-hire/frequently-asked-questions/","https://supplier.gsk.com/irj/portal/public","http://www.gsk.com/en-gb/contact-us/worldwide/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","https://gskpro.com/en-us/","https://gskpro.com/","https://gskpro.com","https://www.gsk.com/en-gb/responsibility/esg-resources/","http://www.gskfunding.com/","https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-best-medicine-disease-patients/","https://www.gsk.com/en-gb/behind-the-science-magazine/men-women-gender-diversity-clinical-trials/","https://www.gsk.com/en-gb/behind-the-science-magazine/maps-technology-new-age-vaccine-development-infectious-diseases/","https://www.gsk.com/en-gb/investors/speeches-and-presentations/","https://www.gsk.com/en-gb/responsibility/environment/climate/","https://contactus.gsk.com/","https://gsk.connectr.co.uk/getahead/","https://www.linkedin.com/company/gsk/","https://x.com/GSKUS?mx=2","https://www.facebook.com/GSK/","https://jobs.gsk.com/?lang=en-us&previousLocale=en-US","https://jobs.gsk.com/en-us/jobs?keywords=%23USCommercialDevelopmentProgram&page=1&sortBy=relevance?keywords=%23USCommercialDevelopmentProgram&page=1&sortBy=relevance&location=United%20States","https://jobs.gsk.com/?lang=en-us&previousLocale=en-US","https://jobs.gsk.com/en-us/jobs?keywords=&location=&lang=en-us?keywords=%23ApprenticeUS2026&page=1&sortBy=relevance&location=United%20States&stretch=10&stretchUnit=MILES?keywords=%23ApprenticeUS2025%20&page=1&sortBy=relevance&location=United%20States","https://www.vaccinetrack.com/Trend?tab=gap&vaccine=9&timePeriod=2021","https://jobs.gsk.com/en-us/jobs?keywords=&location=&lang=en-us","http://tinyurl.com/mrt9buj2","https://jobs.gsk.com/en-gb/jobs?location=Massachusetts,%20United%20States&locations=Boston,Massachusetts,United%20States%7CCambridge,Massachusetts,United%20States%7CWaltham,Massachusetts,United%20States&page=1&stretch=10&stretchUnit=MILES&woe=8","https://jobs.gsk.com/en-us/jobs?keywords=%23USCommercialDevelopmentProgram&sortBy=relevance&page=1&location=United%20States&woe=12®ionCode=US&stretchUnit=MILES&stretch=50","https://jobs.gsk.com/en-us/jobs?keywords=%23USCommercialDevelopmentProgram&page=1&sortBy=relevance&location=United%20States?keywords=%23ApprenticeUS&location=&lang=en-us","https://x.com/GSKUS","https://ourwayforward.com/content/dam/brs-pharma-us/ourwayforward-dtc/en_US/pdfs/oc-patient-discussion-guide.pdf","https://gsk.public.reportum.com/","https://password.gsk.com/password/","https://uksah.gsk.com/swh_uk_win_ns/communications/employee/employees.htm","https://www.vaccinetrack.com/Trend?tab=gap&timePeriod=2022&timePeriod2=2021","https://gskvaccination.com/","https://jobs.gsk.com/en-gb/jobs?lang=en-gb&page=1&location=Massachusetts,%20United%20States&woe=8&stretchUnit=MILES&stretch=10&locations=Boston,Massachusetts,United%20States%7CCambridge,Massachusetts,United%20States%7CWaltham,Massachusetts,United%20States&utm_source=direct&utm_campaign=25453&utm_medium=symphonytalent-misctags&utm_term=43516_Boston%20In-House","https://dontbeembarrassed.com/","https://www.vaccinetrack.com","https://scienceinthesummer.fi.edu/","https://jobs.gsk.com/en-gb/jobs?location=United%20States&locations=Boston,Massachusetts,United%20States%7CCambridge,Massachusetts,United%20States%7CWaltham,Massachusetts,United%20States&page=1&stretch=10&stretchUnit=MILES&woe=8","https://us.gsk.com/en-us/media/press-releases/julie-bowen-and-ty-burrell-team-up-with-gsk-to-raise-awareness-about-meningitis-risks-for-teens-and-young-adults/","https://us.gsk.com/en-us/contact-us/"]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://us.gsk.com/media/kzafk31i/gsk-logo.png?width=104&format=webp&quality=100&v=1dbe12293a58ec0","alt":"Gsk Logo (1)","darkModeSrc":"https://us.gsk.com/media/kzafk31i/gsk-logo.png?width=104&format=webp&quality=90&v=1dbe12293a58ec0"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"70ab0a79-1d92-4286-86d2-abdd71cc785c","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK US"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://us.gsk.com/en-us/media/press-releases/fda-approves-gsk-s-advil-dual-action-with-acetaminophen-for-over-the-counter-use-in-the-united-states/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null}